Pharsight

Drugs that contain Omaveloxolone

1. Skyclarys patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9670147 REATA PHARMS Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
Apr, 2029

(4 years from now)

US8124799 REATA PHARMS Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
Dec, 2029

(5 years from now)

US9701709 REATA PHARMS 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
Apr, 2033

(8 years from now)

US8993640 REATA PHARMS 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
Apr, 2033

(8 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11919838 REATA PHARMS Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
Apr, 2029

(4 years from now)

US11091430 REATA PHARMS Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
Apr, 2029

(4 years from now)

US8440854 REATA PHARMS Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at C-17
Apr, 2029

(4 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-427) Feb 28, 2030
New Chemical Entity Exclusivity(NCE) Feb 28, 2028

NCE-1 date: 28 February, 2027

Market Authorisation Date: 28 February, 2023

Treatment: Method of treating friedrich's ataxia by activating the nrf2 pathway which reduces oxidative stress; Treatment of friedreich's ataxia in adults and adolescents aged 16 years and older

Dosage: CAPSULE;ORAL

More Information on Dosage

SKYCLARYS family patents

Family Patents